Bombshell: CDC No Longer Recognizes the PCR Test As a Valid Method for Detecting “Confirmed Covid-19 Cases”?
(Global Research, Dec 31, 2021)by Professor Michael Chossudovsy)
In the Course of the Next TWO DAYS the PCR test in the US will be Declared Invalid?
The PCR is a Process. It does not tell you that you are sick”. Dr. Kary Mullis, Nobel Laureate and Inventor of the RT-PCR, passed away in August 2019.
This misuse of the RT-PCR technique is applied as a relentless and intentional strategy by some governments to justify excessive measures such as the violation of a large number of constitutional rights, … under the pretext of a pandemic based on a number of positive RT-PCR tests, and not on a real number of patients. .Dr. Pascal Sacré, Belgian physician specialized in critical care and renowned public health analyst.
***
Summary
The PCR Smoking Gun?
As of January 1, 2022, the CDC in a request to the FDA withdraws it’s endorsement of the RT-PCR test.
The CDC acknowledges (with innuendos) that the PCR test does not effectively differentiate between Covid-19 and Seasonal Influenza.
Amply documented and analyzed by numerous scientists, the RT-PCR test does not detect or identify SARS-CoV-2 and its variants.
While the CDC does not officially acknowledge that the RT-PCR test is invalid, it nonetheless calls for it to be withdrawn.
It is worth noting that almost a year ago, in January 2021, the WHO also questioned the validity of the PCR test which it had itself put forth at the very outset of the covid crisis.
If the PCR test is invalid as intimated both by the CDC and the WHO, the 260 Million so-called “Confirmed Covid-19 Cases” collected and tabulated Worldwide since the outset of the alleged pandemic are meaningless.
There is no Pandemic.
In a bombshell decision, the Centers for Disease Control and Prevention (CDC) have withdrawn the insidious PCR test as a valid method for detecting and identifying SARS-CoV-2.
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.”
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing. (emphasis added)
It has taken them almost two years to recognize that the PCR test is flawed and invalid.
Read carefully, what this CDC directive tacitly admits is that the PCR test does not effectively differentiate between “SARS-CoV-2 and influenza viruses”. We have known this from the outset.
This advisory by the CDC issued in July 2021 is to be enforced in the course of the next couple of weeks leading up to the January 1st, 2022 deadline.
Will it be carried out?? Visibly there is no transition towards “another authorized Covid-19 test”.